Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Pages: 1
[FR Doc E8-5628] 1. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
Time and Date: 12:30 p.m.3:30 p.m., April 17, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc E8-5598] 2. Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Norbrook Laboratories, Ltd. The supplemental NADA provides for changing scientific nomenclature for a bovine pathogen on labeling for 300 milligrams per milliliter (mg/mL) strength
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E8-5597] 3. Standards for Standardized Numerical Identifier, Validation, Track and Trace,
The Food and Drug Administration (FDA) is seeking information and comments on issues related to standards for identification, validation, tracking and tracing, and authentication for prescription drug products. Particularly, we are requesting information and comments from drug manufacturers, distributors, pharmacies, other supply chain
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E8-5599] 4. Technologies for Prescription Drug Identification, Validation, Track and
The Food and Drug Administration (FDA) is requesting comments and information regarding technologies used for the identification, validation, tracking and tracing, and authentication of prescription drugs. This request is related to FDA's implementation of the Food and Drug Administration Amendments Act of 2007 (FDAAA).
Elsewhere in this issue
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc E8-5568] 5. National Eye Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc E8-5570] 6. Agency Information Collection Activities: Proposed Collection; Comment
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a
Published: 2008-03-20 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration
Pages: 1